PMC:7104244 / 3802-4205 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"58","span":{"begin":59,"end":69},"obj":"Species"},{"id":"62","span":{"begin":255,"end":263},"obj":"Disease"},{"id":"63","span":{"begin":284,"end":289},"obj":"Disease"},{"id":"64","span":{"begin":291,"end":298},"obj":"Disease"},{"id":"65","span":{"begin":300,"end":309},"obj":"Disease"},{"id":"66","span":{"begin":311,"end":318},"obj":"Disease"},{"id":"67","span":{"begin":320,"end":328},"obj":"Disease"},{"id":"68","span":{"begin":334,"end":342},"obj":"Disease"}],"attributes":[{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"Tax:2697049"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"MESH:C000657245"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:D005334"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:D005221"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D003371"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:D063806"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:D004417"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"MESH:D006261"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"de of clinical guidelines or clinical trials.11\nTo prevent SARS-CoV-2 transmission, we propose additions to the current donor screening measures. In all countries, before each donation, physicians should screen for two main items: the presence of typical COVID-19 symptoms (including fever, fatigue, dry cough, myalgia, dyspnoea, and headache) within the previous 30 days; and the donor's history of tra"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T49","span":{"begin":59,"end":69},"obj":"SP_7"},{"id":"T48","span":{"begin":255,"end":263},"obj":"SP_7"},{"id":"T47","span":{"begin":304,"end":309},"obj":"UBERON:0002048"}],"text":"de of clinical guidelines or clinical trials.11\nTo prevent SARS-CoV-2 transmission, we propose additions to the current donor screening measures. In all countries, before each donation, physicians should screen for two main items: the presence of typical COVID-19 symptoms (including fever, fatigue, dry cough, myalgia, dyspnoea, and headache) within the previous 30 days; and the donor's history of tra"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T16","span":{"begin":59,"end":67},"obj":"Disease"},{"id":"T17","span":{"begin":255,"end":263},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"de of clinical guidelines or clinical trials.11\nTo prevent SARS-CoV-2 transmission, we propose additions to the current donor screening measures. In all countries, before each donation, physicians should screen for two main items: the presence of typical COVID-19 symptoms (including fever, fatigue, dry cough, myalgia, dyspnoea, and headache) within the previous 30 days; and the donor's history of tra"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T33","span":{"begin":45,"end":47},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"de of clinical guidelines or clinical trials.11\nTo prevent SARS-CoV-2 transmission, we propose additions to the current donor screening measures. In all countries, before each donation, physicians should screen for two main items: the presence of typical COVID-19 symptoms (including fever, fatigue, dry cough, myalgia, dyspnoea, and headache) within the previous 30 days; and the donor's history of tra"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":120,"end":125},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_17891"}],"text":"de of clinical guidelines or clinical trials.11\nTo prevent SARS-CoV-2 transmission, we propose additions to the current donor screening measures. In all countries, before each donation, physicians should screen for two main items: the presence of typical COVID-19 symptoms (including fever, fatigue, dry cough, myalgia, dyspnoea, and headache) within the previous 30 days; and the donor's history of tra"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":284,"end":289},"obj":"Phenotype"},{"id":"T2","span":{"begin":291,"end":298},"obj":"Phenotype"},{"id":"T3","span":{"begin":300,"end":309},"obj":"Phenotype"},{"id":"T4","span":{"begin":311,"end":318},"obj":"Phenotype"},{"id":"T5","span":{"begin":320,"end":328},"obj":"Phenotype"},{"id":"T6","span":{"begin":334,"end":342},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0012378"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0031246"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0003326"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0002094"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0002315"}],"text":"de of clinical guidelines or clinical trials.11\nTo prevent SARS-CoV-2 transmission, we propose additions to the current donor screening measures. In all countries, before each donation, physicians should screen for two main items: the presence of typical COVID-19 symptoms (including fever, fatigue, dry cough, myalgia, dyspnoea, and headache) within the previous 30 days; and the donor's history of tra"}

{"project":"LitCovid-sentences","denotations":[{"id":"T11","span":{"begin":48,"end":145},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"de of clinical guidelines or clinical trials.11\nTo prevent SARS-CoV-2 transmission, we propose additions to the current donor screening measures. In all countries, before each donation, physicians should screen for two main items: the presence of typical COVID-19 symptoms (including fever, fatigue, dry cough, myalgia, dyspnoea, and headache) within the previous 30 days; and the donor's history of tra"}